4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-19-051054
Chief Executive Officer sold 20,000 shares at $28.25 ($565,000)
From the SEC's structured data for this filing
Trades in this filing
Anzalone Christopher Richard · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-09-25 | Sale : show line 1 in the form | −20,000 | $28.25 | $565,000 | 2,121,903 | D |
| Open-market sales · 20,000 sh · avg $28.25 · $565,000 | ||||||
Loading xslF345X03/doc4.xml…